Drug Approval | April 21, 2026
Orbicular's partner secures tentative U.S. ANDA approval for a generic version of Ozempic
OneSource is the contract development and manufacturing organization (CDMO) partner for this product
OneSource is the contract development and manufacturing organization (CDMO) partner for this product
As the Clinical Head of Oncology Network, he lead a team of over 25 specialised oncologists
The investment will support the company’s plans to expand its network of specialised surgical hospitals across India.
Medical experts point to a growing body of research linking energy drinks to liver injury
The conclave brought together over 1,000 delegates from across India and internationally
Analysts expect modest revenue growth but pressure on profitability in the March quarter
The approved product is a generic version of Ravicti, originally developed and marketed by Horizon Therapeutics
In his new role, Curtis will lead the formulation and execution of the company’s global technical strategy
Bajaj joins Health Prime after a long and progressive tenure at Concentrix
The study was conducted by PwC India in line with ISO 14040 and ISO 14044 protocols
Subscribe To Our Newsletter & Stay Updated
